News

Published on 20 Jan 2023 on Zacks via Yahoo Finance

New Strong Buy Stocks for January 20th


Article preview image

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

NeuBase Therapeutics, Inc. NBSE: This preclinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 29.5% over the last 60 days.

NeuBase Therapeutics, Inc. Price and Consensus

NASDAQ.PRTG price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
11 Most Volatile Stocks Under $5 For Day Trading

In this piece, we will take a look at the 11 most volatile stocks under $5 for day trading. If yo...

Insider Monkey via Yahoo Finance 4 Dec 2023

New Strong Buy Stocks for January 20th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: NeuBase Therapeutics, In...

Zacks via Yahoo Finance 20 Jan 2023

Best Momentum Stocks to Buy for January 20th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider...

Zacks via Yahoo Finance 20 Jan 2023

How Much Upside is Left in Portage Biotech Inc. (PRTG)? Wall Street Analysts Think 160%

Shares of Portage Biotech Inc. (PRTG) have gained 8.6% over the past four weeks to close the last...

Zacks via Yahoo Finance 16 Dec 2022

New Strong Buy Stocks for November 1st

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: First Financial Northwes...

Zacks via Yahoo Finance 1 Nov 2022

Bears are Losing Control Over Portage Biotech Inc. (PRTG), Here's Why It's a 'Buy' Now

Shares of Portage Biotech Inc. (PRTG) have been struggling lately and have lost 8% over the past ...

Zacks via Yahoo Finance 19 Sep 2022

Nasal and inhaled vaccines are our best hope to stop COVID spread. Why isn't the U.S. funding them?

The first generation of COVID-19 vaccines are injected straight into people’s upper arms. For a...

Fortune 17 Sep 2022

Does Portage Biotech Inc. (PRTG) Have the Potential to Rally 206% as Wall Street Analysts Expect?

Shares of Portage Biotech Inc. (PRTG) have gained 42.7% over the past four weeks to close the las...

Zacks via Yahoo Finance 1 Aug 2022

Portage Biotech Shares Gain On Buying Outstanding Minority Interest In iNKT Platform

Portage Biotech Inc (NASDAQ: PRTG) acquired the remaining 22% stake in its invariant natural kill...

Benzinga via Yahoo Finance 20 Jul 2022

Portage Biotech Bolsters Pipeline With Acquisition Of Four Adenosine Pathway-Targeting Candidates

Portage Biotech Inc (NASDAQ: PRTG) has agreed to acquire Tarus Therapeutics, a private company de...

Benzinga via Yahoo Finance 7 Jul 2022